Mesenchymal Cell News Volume 14.30 | Aug 2 2022

    0
    24








    2022-08-02 | MESCN 14.30


    Mesenchymal Cell News by STEMCELL Technologies
    Vol. 14.30 – 2 August, 2022
    TOP STORY

    Electrically Controlled mRNA Delivery Using a Polypyrrole-Graphene Oxide Hybrid Film to Promote Osteogenic Differentiation of Human Mesenchymal Stem Cells

    Investigators reported a new conductive hybrid film that could guide osteogenic differentiation of human adipose-derived MSCs via electrically controlled mRNA delivery.
    [Nano Research]

    AbstractGraphical Abstract
    ON1083HSC-StemSpanAOF-external-728x90-1
    PUBLICATIONSRanked by the impact factor of the journal

    Injectable Hydrogel with Immobilized BMP-2 Mimetic Peptide for Local Bone Regeneration

    Bone morphogenetic protein-2 (BMP-2) peptides presented in soluble and immobilized form increased alkaline phosphatase expression in MSCs cultured on 2D and encapsulated in 3D norbornenetetrazine hydrogels.
    [Frontiers in Biomaterials Science]

    Full Article

    Mesenchymal Stem Cells Exert Renoprotection via Extracellular Vesicle-Mediated Modulation of M2 Macrophages and Spleen-Kidney Network

    Scientists reported the therapeutic actions of human adipose-derived MSCs in nephritis, focusing on cellular dynamics and multi-organ networks.
    [Communications Biology]

    Full Article

    TGF-β1-Induced Bone Marrow Mesenchymal Stem Cells (BMSCs) Migration via Histone Demethylase KDM6B Mediated Inhibition of Methylation Marker H3K27me3

    The authors focused on the epigenetic mechanisms in MSC migration. TGF-β1 stimulated bone marrow MSCs to promote cell migration at lesion sites in vitro and in vivo.
    [Cell Death Discovery]

    Full Article

    Enhanced Migration and Immunoregulatory Capacity of BMSCs Mediated by Overexpression of CXCR4 and IL-35

    Scientists developed dual gene modification of bone marrow-derived MSCs (BMSCs) and found that the migration and immunomodulatory activity of genetically engineered BMSCs were significantly enhanced compared to their natural counterparts.
    [Molecular Immunology]

    Full ArticleGraphical Abstract

    Comparison of the Enhanced Attachment and Proliferation of the Human Mesenchymal Stem Cells on the Biomimetic Nanopatterned Surfaces of Zein, Silk Fibroin, and Gelatin

    Zein, a plant protein, was utilized to make patterned surface mimicking the extracellular matrix to assist the attachment and proliferation of stem cells.
    [Journal of Biomedical Materials Research Part B-Applied Biomaterials]

    Abstract

    Safrole Oxide Induced 5-HT Neuron-Like Cell Differentiation of Bone Marrow Mesenchymal Stem Cells by Elevating G9a

    Researchers found that safrole oxide could induce bone marrow MSC differentiation into 5-hydroxytryptamine (5-HT) neuron-like cells.
    [In Vitro Cellular & Developmental Biology – Animal]

    Abstract

    Reprogramming Adipose Mesenchymal Stem Cells into Islet β-Cells for the Treatment of Canine Diabetes Mellitus

    Pbx1, Rfx3, Pdx1, Ngn3, Pax4 and MafA were used to form a six-gene combination to efficiently reprogram adipose MSCs (aMSCs) into reprogrammed aMSCs-derived islet β-cells.
    [Stem Cell Research & Therapy]

    Full Article

    Bone Marrow Mesenchymal Stem Cells Inhibit Hepatic Fibrosis via the AABR07028795.2/Rno-miR-667-5p Axis

    TGF-β1-induced hepatic stellate cell-T6 and CCl4-induced hepatic fibrosis rats were treated with bone marrow MSCs.
    [Stem Cell Research & Therapy]

    Full Article

    The Immunology Podcast is here. Find it wherever you get your podcasts.
    REVIEWS

    Bone Marrow Mesenchymal Stromal Cells for Diabetes Therapy: Touch, Fuse, and Fix?

    The authors discuss the cell-protective and anti-inflammatory characteristics of bone marrow-MSCs to boost highly functional insulin-producing cells in vitro and in vivo.
    [Stem Cell Research & Therapy]

    Full Article

    Mesenchymal Stem Cells in Fibrotic Diseases — the Two Sides of the Same Coin

    Investigators discuss the two opposite roles of residential MSCs and external MSCs in fibrotic diseases, and summarize the current perspective of the therapeutic mechanism of MSCs in fibrosis, through both laboratory study and clinical trials.
    [Acta Pharmacologica Sinica]

    Full Article

    INDUSTRY AND POLICY NEWS

    UF Center for Regenerative Medicine Recruiting for Trial on Potential Therapy for Autoimmune Disorders

    The University of Florida (UF) Center for Regenerative Medicine announced the launch of a clinical trial to test safe dosages of umbilical cord-derived stem cells in the treatment of two debilitating autoimmune disorders.
    [University of Florida Health]

    Press Release
    FEATURED EVENT

    Till & McCulloch Meetings

    October 3 – 5, 2022
    Vancouver, British Columbia, Canada

    > See All Events

    JOB OPPORTUNITIES

    PhD Student – Bioinformatics

    German Cancer Research Center in the Helmholtz Association – Dresden, Germany

    Postdoctoral Researcher – Immuno-Oncology

    Essen University Hospital – Essen, Germany

    Postdoctoral Position – Cancer Biology and Immunotherapies

    Sanford Research – Sioux Falls, South Dakota, United States

    Associate Professor – Thematic Research Programs

    The Chinese University of Hong Kong – Hong Kong, China

    Director – Bone & Soft Tissue Pathology

    Michigan Medicine – Ann Arbor, Michigan, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Mesenchymal Cell News Twitter